PRME: Prime Medicine Operatsion marja

primemedicine.com (PRME) - korporativ logo

Prime Medicine, Inc. (PRME) rahbariyati operatsion marja tendentsiyalari bilan tasdiqlanganidek, tadqiqot va ishlanmalar (R&D) bosqichlarida kapitalni samarali taqsimlamoqda. -2584.20 qiymati ushbu ko'rsatkichning joriy darajasini ko'rsatadi. Robotlashtirilgan stansiyalarning joriy etilishi DNK terapiyalarining ishlab chiqilishini tezlashtirib, zamonaviy tibbiyot uchun bazaviy standartga aylanishi mumkin bo'lgan noyob "qidirish va almashtirish" genetik kod ekotizimini yaratmoqda.

PRME - primemedicine.com Operatsion foyda normasi 28.04.2023 - 20.11.2026 oraligʻida

Prime Medicine, Inc. (PRME) kompaniyasining tahliliy kesimlari

Kompaniyaning har tomonlama tahlili:Prime Medicine Bio
Prime Medicine Bio asosiy tovari

Prime Medicine, Inc. (PRME) ko'plab irsiy patologiyalarni davolash uchun innovatsion aniqlikdagi genom tahrirlash instrumentlari to'plamini ishlab chiqmoqda. Operatsion marja grafigi ushbu R&D bosqichlarida xarajatlarni boshqarish samaradorligini ko'rsatadi. Ushbu ko'rsatkich operatsion daromadning tushumga nisbati sifatida hisoblanadi va moliyaviy majburiyatlar hisobga olinishidan oldin biznesning daromad keltirish qobiliyatini o'lchaydi. Ushbu nisbatning barqarorligi kapital qiymati bo'yicha bozor konsensusini tasdiqlaydi, bu esa kelajakdagi pul oqimlarining noaniqligi bilan bog'liq investitsiya risklarini kamaytiradi.

Raqobatchilar tahlili

Sotuvning operatsion marjasi TEM|QGEN - Operatsion foyda bo'yicha marjinallik|Operatsion marja IONS|RGEN - Sotuvning operatsion rentabelligi|Operatsion rentabellik Avidity RNA|Operatsion marja CRISPR Therapeutics Corp CRSP|GeneDx Corp - Operatsion marja|Ultragenyx Pharma (RARE) - Sotuvning operatsion marjasi|beamtx.com (BEAM) - Operatsion rentabellik|SRPT: Operatsion foyda koeffitsiyenti|Sotuvning operatsion marjasi TWST|TXG - Operatsion foyda bo'yicha marjinallik|Operatsion marja NTLA|Operatsion faoliyat rentabelligi Stoke Therapeutics|Operatsion rentabellik BioLife Solutions BLFS|Wave Life Sciences (WVE) - Sotuvning operatsion rentabelligi|Maze Therapeutics, Inc. - Operatsion marja|Operatsion faoliyat rentabelligi Sionna Therapeutics, Inc. SION|TSHA (Taysha Gene Therapies, Inc.) - Sotuvning operatsion marjasi|QURE - Operatsion faoliyat rentabelligi|MGTX (MeiraGTx Corp) - Operatsion marja|Sotuvning operatsion rentabelligi REGENXBIO Inc. RGNX|Operatsion rentabellik Solid Biosciences (SLDB)|Ocugen Corp - Operatsion foyda bo'yicha sotuv rentabelligi|Operatsion rentabellik Pacific Biosciences PACB|Operatsion foyda koeffitsiyenti BNTC (Benitec)|Design Corp - Operatsion marja|Rocket Pharmaceuticals - Operatsion foyda koeffitsiyenti|Operatsion foyda bo'yicha sotuv rentabelligi 4D Molecular Therapeutics, Inc.|Sotuvning operatsion rentabelligi Lexeo Therapeutics (LXEO)|KRRO (Korro Bio, Inc.) - Operatsion marja|Sotuvning operatsion rentabelligi Editas EDIT|Operatsion marja SLN|ProQR Therapeutics - Operatsion foyda bo'yicha sotuv rentabelligi|Operatsion marja CDXS (Codexis, Inc.)|SGMO: Operatsion foyda bo'yicha sotuv rentabelligi|Nautilus Biotechnology - Operatsion marja|Operatsion foyda normasi MGX (Metagenomi, Inc)|DTIL: Operatsion marja|GBIO: Operatsion foyda koeffitsiyenti|Operatsion rentabellik Boundless Bio Inc.|Sotuvning operatsion marjasi Exicure (XCUR)|Operatsion marja IMNN|PHIO (Phio Pharmaceuticals Corp.) - Operatsion foyda normasi|Mustang Bio, Inc. - Sotuvning operatsion marjasi|RNAZ - Sotuvning operatsion marjasi|BNGO: Sotuvning operatsion marjasi|APDN (Applied DNA Sciences Inc) - Operatsion foyda bo'yicha sotuv rentabelligi|BLUE (Bluebird Bio) - Sotuvning operatsion marjasi|ImmunoPrecise Antibodies Ltd - Operatsion foyda normasi|OMGA (Omega Therapeutics Inc) - Operatsion marja|Operatsion rentabellik OMIC|Operatsion rentabellik Regulus Therapeutics Inc. (RGLS)|Sotuvning operatsion marjasi Syros Pharmaceuticals, Inc. SYRS|Telesis Bio - Sotuvning operatsion marjasi|Operatsion foyda normasi TCON|UBX - Operatsion rentabellik